TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04225585

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CST-PSP
Description: skills training and experiential learning exercises

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: General health education
Description: general health education intervention that focuses on improving overall health

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: General health education
Description: general health education intervention that focuses on improving overall health
Study: NCT04499326

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Validated quality of life questionnaire (EQ-5D & C-CAP)
Description: Patient quality of life to be assessed at baseline, 1, 2, 3, 4, 6, 9 and 12 months

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Validated quality of life questionnaire (EQ-5D & C-CAP)
Description: Patient quality of life to be assessed at baseline, 1, 2, 3, 4, 6, 9 and 12 months
Study: NCT04558619

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Kōmmour Prenatal
Description: Centering Pregnancy, a group prenatal care model, is a promising intervention that challenges the standard model of one-on-one counseling of prenatal care. The model, is currently implemented at the UAMS, but as of yet to be adapted for Pacific Islanders. Centering Pregnancy replaces the individual prenatal care visit with a group model for obstetrically low-risk women. This model provides substantially more health promotion content than the traditional one-on-one prenatal care model. The intervention occurs from week 14 of pregnancy through birth, following the same same schedule as individual care. Group visits are 90-120 minutes each and follow a unique structured curriculum that incorporates standards of care. In the group setting, credentialed prenatal providers conduct a one-on-one assessment with each patient (30 min) and then facilitate group discussions on the topics of pregnancy, using adult learning principles (60-90 min).
Study: NCT04050735

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Alcohol, ethyl, moderate dose
Description: Moderate oral dose of ethyl alcohol

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo beverage
Study: NCT04541537

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Sorbstar®
Description: Thermodesorption method coupled with full two-dimensional gas chromatography and mass spectrometry

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Dog Detection
Description: Analysed by the dogs of Curie Institute at the training centers
Study: NCT04693767

Intervention type: DEVICE
Intervention: Mechanical thrombectomy
Description: 1. Clot specimen collection~2. Extracranial blood collection
Study: NCT06042010

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral zinc supplement
Description: patients received oral Zinc picolinate 50mg for 6 weeks as single morning dose along with 0.1%

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: triamcinolone acetonide Oral paste
Description: patients will received 0.1%triamcinolone acetonide Oral paste twice daily alone for 6weeks.
Study: NCT05132283

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 3D Slicer
Description: Navigational device used during surgery to locate abnormal lymph nodes.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Monaco
Description: Navigational device used during surgery to locate abnormal lymph nodes.
Study: NCT05321888

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Mechanical Ventilation
Description: Standard Protocol

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mechanical Ventilation with Postural drainage
Description: This Group will be treated by postural drainage and mechanical ventilation for two consecutive days
Study: NCT04725396

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mandibular Reconstruction (MR) with Preoperative Virtual Planning (PVP).
Description: PVP-assisted mandibular reconstruction includes the production of the surgical cutting guides required for mandibular resection and fibula free-flap conformation and of the preformed plates for flap osteosynthesis (for all patients, PVP will be done by the same laboratory).

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Mandibular Reconstruction (MR without PVP)
Description: Conventional Mandibular Reconstruction
Study: NCT06455150

Intervention type: OTHER
Intervention: Assessment of pelvic floor dysfunctions' symptoms and sings, pelvic floor muscle strength and quality of life
Description: It will be assessed the presence of urinary incontinence, anal incontinence, pelvic organ prolapse and female sexual dysfunction' symptoms by using the questionaries validated to Spanish population International Consultation on Incontinence Questionnaire-Short Form, Pelvic Floor Distress Inventory Short Form and Female Sexual Function Index; in addition, the sign of stress urinary incontinence and pelvic organ prolapse will be assessed by using the cough stress test and Pelvic Organ Prolapse Quantification System, the pelvic floor muscle strength by using manometry, and quality of life by using SF-12 questionnaire.

Intervention type: OTHER
Intervention: Assessment of pelvic floor dysfunctions' symptoms and sings, pelvic floor muscle strength and quality of life
Description: It will be assessed the presence of urinary incontinence, anal incontinence, pelvic organ prolapse and female sexual dysfunction' symptoms by using the questionaries validated to Spanish population International Consultation on Incontinence Questionnaire-Short Form, Pelvic Floor Distress Inventory Short Form and Female Sexual Function Index; in addition, the sign of stress urinary incontinence and pelvic organ prolapse will be assessed by using the cough stress test and Pelvic Organ Prolapse Quantification System, the pelvic floor muscle strength by using manometry, and quality of life by using SF-12 questionnaire.
Study: NCT06298253

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral economics-enhanced SWAP implementation
Description: Intervention will include behavioral nudges at baseline and over 12 months to promote use of the SWAP nutrition program for pantries.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Basic SWAP implementation
Description: Intervention will include basic information about the SWAP program and encouragement to obtain SWAP toolkits.
Study: NCT06312280

Intervention type: BEHAVIORAL
Intervention: Mediterranean diet
Description: The composition of the diet will be distributed as follows: 55-60% of carbohydrates (45-50% complex carbohydrates and no more than 10% of simple sugars), 25-30% of lipids and 15% of proteins. It will be studied in accordance with the LARN (Italian Society of Human Nutrition, 2014) guidelines.
Study: NCT06353438

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise Program
Description: Concentric strengthening of multiple muscle groups 2x/week for 6 weeks.
Study: NCT05455138

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Arterial bypass grafting
Description: Arterial bypass grafting in patients with critical limb ischemia due to peripheral artery disease

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Arterial bypass grafting
Description: Arterial bypass grafting in patients with critical limb ischemia due to peripheral artery disease

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Arterial bypass grafting
Description: Arterial bypass grafting in patients with critical limb ischemia due to peripheral artery disease

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Arterial bypass grafting
Description: Arterial bypass grafting in patients with critical limb ischemia due to peripheral artery disease
Study: NCT05764993

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CUVITRU - Ig subcutaneous human 20%
Description: Subcutaneous Immunoglobin Replacement Therapy, SCigR

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard Medical Therapy
Description: Standard Medical Therapy

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Standard Medical Therapy
Description: Standard Medical Therapy
Study: NCT05137353

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music Training (RitMoZ Training)
Description: This training is inspired by intervention concepts followed in SUVAG Polyclinic in Zagreb, Croatia and Kodaly pedagogy in Hungary. RitMoZ Training programme consists of 6 main activities: matching activity, nursery rhymes, rhythmic stimulations, music shapes, music writing and music reading. The training focuses on the perceptual overlap between language and music, embodiment and entrainment. The aim of the training is to improve characteristic features of reading disorders such as phonological awareness, perception of rhythm, phonological working memory and perception of speech sounds.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Spelling Training
Description: This training consists of activities which focus on practicing spelling words in a computer task; the aim is to train orthographic processing which is suggested to improve phonological awareness and phonological working memory.
Study: NCT04647630

Intervention type: DIAGNOSTIC_TEST
Intervention: urine test
Description: test for pneumococcal antigen in urine
Study: NCT05854433

Intervention type: OTHER
Intervention: Non-interventional study
Description: No intervention will be administered as part of this study.

Intervention type: OTHER
Intervention: Non-interventional study
Description: No intervention will be administered as part of this study.
Study: NCT05003960

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AlloRx
Description: cultured allogeneic adult umbilical cord derived mesenchymal stem cells
Study: NCT05997498

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: mechanical cervical dilatation
Description: mechanical cervical dilatation during elective cesarean section
Study: NCT04902833

Intervention type: PROCEDURE
Intervention: Blood Draw
Description: Blood specimen 2-4 teaspoons

Intervention type: PROCEDURE
Intervention: Blood Draw
Description: Blood specimen 2-4 teaspoons
Study: NCT05658237

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pars plana vitrectomy
Description: One sheet of PAL-222 is implanted into the subretinal space of either of eyes through pars plana vitrectomy.
Study: NCT04667078

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cangrelor
Description: administration of cangrolor by iv befor thrombectomy

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: best medical management
Description: used yhe best medical management
Study: NCT05872360

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Bundle Group 1 with Nutrilite Lifestyle
Description: All-plant protein booster: 2 spoons (15g), twice per day. Calcium \& Magnesium：3 tablets one time per day. Glucosamine: 2 tablets two times per day. 20 minutes training with EMS (Electric Muscle Stimulation) per day. Practice according to Nutrilite Lifestyle Guideline per day.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Bundle Group 2 without Nutrilite Lifestyle
Description: All-plant protein booster: 2 spoons (15g), twice per day. Calcium \& Magnesium：3 tablets one time per day. Glucosamine: 2 tablets two times per day. 20 minutes training with EMS (Electric Muscle Stimulation) per day.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Control Group 1
Description: Placebo: 2 spoons (15g), twice per day. Placebo for Calcium \& Magnesium：3 tablets one time per day. Placebo for Glucosamine: 2 tablets two times per day.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Control Group 2 with Nutrilite Lifestyle
Description: Placebo: 2 spoons (15g), twice per day. Placebo for Calcium \& Magnesium：3 tablets one time per day. Placebo for Glucosamine: 2 tablets two times per day. Practice according to Nutrilite Lifestyle Guideline per day.
Study: NCT04693767

Intervention type: OTHER
Intervention: Minimally invasive surgery
Description: 1. Clot specimen collection~2. Arterial blood collection
Study: NCT06451406

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Selective serotonin re-uptake inhibitor
Description: Patients received selective serotonin re-uptake inhibitor as medical treatment for treatment of premature ejaculate.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid
Description: Patients received injection of glans penis with hyaluronic acid
Study: NCT06651684

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CanCEASE with Health Navigator
Description: CanCEASE is a digital intervention to identify parents who smoke, assess their motivation and willingness to quit, as well as to provide direct linkage to evidence-based smoking interventions, including effective behavioural and pharmacological resources that can be used alone or in combination.~Participants will have the choice to receive CanCEASE at three timepoints (0, 6 and 12 months). CanCEASE will be combined with an offer of support sessions with a Health Navigator.~Health Navigators will be research personnel hired specifically for this study and trained formally in health navigation, tobacco cessation counseling and strategies to address unmet social needs. The investigators will leverage knowledge and experience of two ongoing RCTs of HNs in pediatrics to inform training strategies.
Study: NCT06653114

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education in Chronic Musculoskeletal Pain
Description: Improving Knowledge and Skills in Chronic Musculoskeletal Pain (Assessment and Management)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education in Communication Skills
Description: Developing Communication Skills (Empathy, Motivational Interviewing, Shared Decision-making)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education in Communication Skills
Description: Developing Communication Skills (Empathy, Motivational Interviewing, Shared Decision-making)
Study: NCT06655272

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bacterial Lysate
Description: Administration p.o. for 10 days per month for 3 months, two consecutive cycles.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo.
Study: NCT06653972

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pegylated Liposomal Doxorubicin + vinorelbine,every cycle is 14d.
Description: Pegylated Liposomal Doxorubicin 25mg/m2 ivgtt d1 + vinorelbine25mg/m2 ivgtt d1/q14d.
Study: NCT06655350

Intervention type: OTHER
Intervention: MRI
Description: Morphological data on the tendon (appearance) will be collected on the harvested side and on the healthy side from an MRI analysis carried out systematically after Haemi-Castaing-type surgery.

Intervention type: OTHER
Intervention: MRI
Description: Morphological data on the tendon (appearance) will be collected on the harvested side and on the healthy side from an MRI analysis carried out systematically after Haemi-Castaing-type surgery.

Intervention type: OTHER
Intervention: Measure
Description: Morphological data on the tendon (diameter) will be collected on the harvested side and on the healthy side from an MRI analysis carried out systematically after Haemi-Castaing-type surgery.

Intervention type: OTHER
Intervention: Measure
Description: Morphological data on the tendon (diameter) will be collected on the harvested side and on the healthy side from an MRI analysis carried out systematically after Haemi-Castaing-type surgery.
Study: NCT06655805

Intervention type: DEVICE
Intervention: Non-invasive ventilation, Invasive mechanical ventilation, high-flow nasal oxygen
Description: No intervention is intended by the nature of this observational study.
Study: NCT06653985

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hyaluronic and corticosteroid injection
Description: Patients will receive an ultrasound-guided injection consisting of 3 ml hyaluronic acid (Durolane™) mixed with 40 mg triamcinolone (Kenalog™) into their hip joint.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hyaluronic and corticosteroid injection
Description: Patients will receive an ultrasound-guided injection consisting of 3 ml hyaluronic acid (Durolane™) mixed with 40 mg triamcinolone (Kenalog™) into their hip joint.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical Therapy
Description: Patients will receive an 8-week physiotherapy protocol, consisting of 8 visits. The protocol will consist of 1 visit per week.
Study: NCT06590818

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: High tibial osteotomy (HTO
Description: To investigate the effect of body mass index (BMI) on the early efficacy of high tibial osteotomy (HTO) in the treatment of varus knee osteoarthritis
Study: NCT06603779

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Ultasound Therapy
Description: a device that transmit ultrasound waves to the participant through direct contact

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Integrated Neuromuscular technique
Description: Integrated Neuromuscular technique is a kind of Manual therapy which include Ischemic Compression, Strain counter-strain and muscle energy technique

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cervical and Scapular Stabilization exercises
Description: Cervical and Scapular Stabilization exercises are a group of therapeutic exercises.
Study: NCT06597123

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Basic AI (artificial intelligence)-Augmented Motivational Interviewing Training
Description: Basic participants will participate in two motivational interviewing (MI) training sessions that involve role-play practice of MI. Artificial intelligence (AI) will be used to provide metrics on MI-skills (percentage of the time the clinician talks, use of open-ended questions, use of closed-ended questions, use of reflective statements, use of 0-10 scales) as measured by the ReadMI™ tool (Real-time Evaluation of Dialogue in Motivational Interviewing), and both the spirit of MI and presence of bias as measured by Dougall GPT.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Plus AI (artificial intelligence)-Augmented Motivational Interviewing Training
Description: Plus participants will participate in four motivational interviewing (MI) training sessions that involve role-play practice of MI. Artificial intelligence (AI) will be used to provide metrics on MI-skills (percentage of the time the clinician talks, use of open-ended questions, use of closed-ended questions, use of reflective statements, use of 0-10 scales) as measured by the ReadMI™ tool, and both the spirit of MI and presence of bias as measured by Dougall GPT.
Study: NCT06594029

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Community Navigator Intervention
Description: see previous section

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Group
Description: Participants receive information on how to increase their community participation
Study: NCT06597773

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Online patient navigation and supportive care referrals
Description: In the online patient navigation program, a navigator will use validated instruments to identify participants\&amp;#39; need for nutrition, psychology, and sexology counseling, and will refer them to the required services. Referrals will be made to web-based, systematic supportive care resources consisting of pre-recorded videos led by specialists and which will be available on a study-specific website, allowing each participant to access the resources as soon as they receive a referral. Additionally, online support groups will be held monthly to complement the supportive care programs.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: In-person patient navigation and supportive care referrals
Description: In the in-person patient navigation program, a navigator will use validated instruments to identify participants\&amp;#39; need for nutrition, psychology, and sexology counseling, and will refer them to the required services. Referrals will be made to supportive care services available at their healthcare institution.
Study: NCT06587503

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BioNTech - Pfizer COVID-19 vaccine
Description: Vaccine for protection from COVID-19

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: 1mL saline solution
Description: Placebo

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: rVSV∆G-ZEBOV-GP
Description: Vaccine for protection from Zaire Ebola virus

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: rVSV∆G-ZEBOV-GP
Description: Vaccine for protection from Zaire Ebola virus
Study: NCT06587945

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Nicotinamide Riboside
Description: Oral Nicotinamide Riboside, 2g daily for 4 weeks followed by 1g daily for 16 weeks

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matched placebo

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Vitrectomy and Gas tamponade
Description: Standard of care Vitrectomy surgery for retinal reattachment

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Vitrectomy and Gas tamponade
Description: Standard of care Vitrectomy surgery for retinal reattachment
Study: NCT06600724

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: Beginning at the screening visit, participants will receive weekly treatment with standard of care (cleaning, debridement, ulcer moisture balance, and offloading) until ulcer closure, or a maximum of 12 weeks, whichever occurs first.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EPIEFFECT
Description: Participants will receive weekly applications of EPIEFFECT and Standard of Care until ulcer closure, or a maximum of 12 weeks, whichever occurs first

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EPIXPRESS
Description: Participants will receive weekly applications of EPIXPRESS and Standard of Care until ulcer closure, or a maximum of 12 weeks, whichever occurs first
Study: NCT06093126

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lemborexant 5 MG
Description: The participant will receive 8 weeks of treatment Week 1 = placebo Week 2 = lemborexant 5mg Week 3 = lemborexant 10 mg Week 4 = placebo Week 5 = lemborexant 10 mg Week 6 = placebo Week 7 = placebo Week 8 = lemborexant 10 mg
Study: NCT06599541

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hypopressive Exercise
Description: A hypopressive exercise program will be carry out.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pilates Exercise
Description: A pilates exercise program will be carry out.